Glucocorticoid receptor in human respiratory epithelial cells

NeuroImmunoModulation

Volumn 16, Issue 5, 2009, Pages 290-299

  Pujolsa, Laura ^a   Mullol, Joaquim ^a   Picado, Cèsar ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Airway inflammation; Airway respiratory diseases; Glucocorticoid; Glucocorticoid receptor isoforms; Respiratory airway epithelial cells

Indexed keywords

BUDESONIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; DOWN REGULATION; EPITHELIUM CELL; GENE REPRESSION; HUMAN; INFLAMMATORY CELL; NOSE POLYP; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RESPIRATORY EPITHELIUM; REVIEW; RHINOSINUSITIS; TRANSACTIVATION;

GLUCOCORTICOIDS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; INFLAMMATION MEDIATORS; RECEPTORS, GLUCOCORTICOID; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM;

EID: 67651089737     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216187     Document Type: Review

References (85)

1. Schleimer RP: Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 2004;1:222-230.
2. Stellato C: Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets. J Allergy Clin Immunol 2007;120: 1247-1263.
3. GINA 2006 Workshop Report: Global strategy for asthma management and prevention. WHO/NHLBI workshop report: National Institutes of Health, National Heart, Lung and Blood Institute, Publ. No. 95-3659, updated 2004.
4. Bousquet J, van Cauwenberge P, and members of the ARIA Science Committee: Phar-macologic and anti-IgE treatment of allergic rhinitis. ARIA update (in collaboration with GA2LEN). Allergy 2006;61: 1086-1096.
5. Fokkens W, Lund V, Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps Group: European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;20:1-136.
6. Stahn C, Löwenberg M, Hommes DW, Buttgereit F: Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 2007;275: 71-78.
7. Rhen T, Cidlowski JA: Anti-inflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 2005;353:1711-1723.
8. Ito K, Chung KF, Adcock IM: Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006;117:522-543.
9. Lu NZ, Cidlowski JA: Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol 2006;16:301-307.
10. Duma D, Jewell CM, Cidlowski JA: Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 2006;102:11-21.
11. Pujols L, Mullol J, Picado C: Alpha- and beta-glucocorticoid receptors: relevance in airway diseases. Curr Allergy Asthma Rep 2007;7: 93-99.
12. Kassel O, Herrlich P: Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 2007;275:13-29.
13. Heitzer MD, Wolf IM, Sánchez ER, Witchel SF, DeFranco DB: Glucocorticoid receptor physiology. Rev Endocr Metab Disord 2007;8:321-330.
14. Clark AR: Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 2007;275: 79-97.
15. Turner JD, Schote AB, Macedo JA, Pelascini LPL, Muller CP: Tissue-specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochem Pharmacol 2006;72: 1529-1537.
16. Oakley RH, Sar M, Cidlowski JA: The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 1996;271:9550-9559.
17. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA: Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol Cell Biol 2007;27: 2266-2282.
18. Lu NZ, Cidlowski JA: Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005;18: 331-342.
19. Lu NZ, Collins JB, Grissom SF, Cidlowski JA: Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol 2007;27: 7143-7160.
20. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcodk IM: Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 2006;203: 7-13.
21. Ito K, Charron CE, Adcodk IM: Impact of protein acetylation in inflammatory lung diseases. Pharmacol Ther 2007;116: 249-265.
22. Tao T, Lan J, Lukacs GL, HachéRJ, Kaplan F: Importin-13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. Am J Respir Cell Mol Biol 2006;35: 668-680.
23. Pujols L, Mullol J, Torrego A, Picado C: Glucocorticoid receptors in human airways. Allergy 2004;59:1042-1052.
24. Kinyamu HK, Chen J, Archer TK: Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 2005;34:281-297.
25. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP, Bornstein SR: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002;16: 61-71.
26. Perreti M: Glucocorticoids in innate immunity: more transactivation than transrepres-sion. Blood 2007;109:852-853.
27. Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, Zuraw BL: The antiinflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 2007;119:115-122.
28. Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ, Adcock IM: Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 2005;172: 704-712.
29. Smoak K, Cidlowski JA: Glucocorticoids regulate tristetraprolin synthesis and post-transcriptionally regulate tumor necrosis factor α inflammatory signaling. Mol Cell Biol 2006;26: 9126-9135.
30. 2-agonists differentially regulate rhinovirus-in-duced interleukin-6 via distinct cis-acting elements. J Biol Chem 2007;282: 15366-15375.
31. Chen Y, Nickola TJ, DiFronzo NL, Colberg-Poley AM, Rose MC: Dexamethasone-medi-ated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2006;34: 338-347.
32. Tasker JG, Di S, Malcher-Lopes R: Rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 2006;147: 5549-5556.
33. Urbach V, Verriere V, Grumbach Y, Bous-quet J, Harvey BJ: Rapid anti-secretory effects of glucocorticoids in human airway epithelium. Steroids 2006;71: 323-328.
34. Hecht K, Carlstedt-Duke J, Stierna P, Gus-tafsson JÅ, Brönnegård M, Wikström AC: Evidence that the β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 1997;272:26659-26664.
35. De Lange P, Koper JW, Huizinga NATM, Brinkman AO, de Jong FH, Karl M, Chrousos GP, Lamberts SW: Differential hormone-dependent transcriptional activation and repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol 1997;11: 1156-1164.
36. Brogan IJ, Murray IA, Cerillo G, Needham M, White A, Davis JRE: Interaction of glucocorticoid receptor isoform with transcription factors AP-1 and NF- κB: lack of effect of glucocorticoid receptor β. Mol Cell Endocrinol 1999;157: 95-104.
37. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA: The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action. J Biol Chem 1999;274:27857-27866.
38. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP: Glucocorticoid receptor p, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995;95: 2435-2441.
39. Gougat C, Jaffuel D, Gagliardo R, Henriquet C, Bousquet J, Demoly P, Mathieu M: Over-expression of the human glucocorticoid receptor α and β isoforms inhibits AP-1 and NF-κB activities hormone independently. J Mol Med 2002;80:309-318.
40. De Lange, Koper JW, Brinkmann AO, de Jong FH, Lamberts SWJ: Natural variants of the β isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids. Mol Cell Endocrinol 1999;153:163-168.
41. Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DY: High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001;193:585-594.
42. Hauk PJ, Goleva E, Strickland I, Vottero A, Chrousos GP, Kisich KO, Leung DY: Increased glucocorticoid receptor β expression converts mouse hybridoma cells to a cortico-steroid-insensitive phenotype. Am J Respir Cell Mol Biol 2002;27: 361-367.
43. Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA: Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol 2003;23: 4319-4330.
44. Charmandari E, Chrousos GP, Ichijo T, Bhattacharyya N, Vottero A, Souvatzoglou E, Kino T: The human glucocorticoid receptor (hGR)-β isoform suppresses the transcriptional activity of hGR-α by interfering with formation of active coactivator complexes. Mol Endocrinol 2005;19:52-64.
45. Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY: Increased glucocorticoid receptor β alters steroid response in glucocorticoid- insensitive asthma. Am J Respir Crit Care Med 2006;173:607-616.
46. Kelly A, Bowen H, Jee YK, Mahfiche N, Soh C, Lee T, Hawrylowicz C, Lavender P: The glucocorticoid receptor β isoform can mediate transcriptional repression by recruiting histone deacetylases. J Allergy Clin Immunol 2008;121: 203-208.
47. Verheggen MM, van Hal PT, Adriaansen-Soeting PW, Goense BJ, Hoogsteden HC, Brinkmann AO, Versnel MA: Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1β, TNF-α and LPS. Eur Respir J 1996;9:2036-2043.
48. LeVan TD, Behr FD, Adkins KK, Miesfeld RL, Bloom JW: Glucocorticoid receptor signaling in a bronchial epithelial cell line. Am J Physiol 1997;272:L838-L843.
49. LeVan TD, Babin EA, Yamamura HI, Bloom JW: Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells. Biochem Pharmacol 1999;57: 1003-1009.
50. Pujols L, Mullol J, Roca-Ferrer J, Torrego A, Xaubet A, Cidlowski JA, Picado C: Expression of glucocorticoid receptor α- and β-iso-forms in human cells and tissues. Am J Physiol 2002;283:C1324-C1331.
51. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ: Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996;154: 771-782.
52. Pujols L, Mullol J, Pérez M, Roca-Ferrer J, Juan M, Xaubet A, Cidlowski JA, Picado C: Expression of the human glucocorticoid receptor α and β isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Respir Cell Mol Biol 2001;24: 49-57.
53. Pujols L, Xaubet A, Ramírez J, Mullol J, Roca-Ferrer J, Torrego A, Cidlowski JA, Pica-do C: Expression of glucocorticoid receptor α and β in steroid-sensitive and -insensitive interstitial lung diseases. Thorax 2004;59: 687-693.
54. Yun CB, Lee BH, Jang TJ: Expression of glucocorticoid receptors and cyclooxygenase-2 in nasal polyps from nonallergic patients. Ann Otol Rhinol Laryngol 2002;111: 61-67.
55. Pujols L, Alobid I, Benítez P, Martínez-Antón A, Roca-Ferrer J, Fokkens WJ, Mulloll J, Picado C: Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Allergy 2008;63:1377-1386.
56. Korn SH, Wouters EF, Wesseling G, Arends JW, Thunnissen FB: In vitro and in vivo modulation of α- and β-glucocorticoid-receptor mRNA in human bronchial epithelium. Am J Respir Crit Care Med 1997;155: 1117-1122.
57. Knutsson PU, Brönnegård M, Marcus C, Stierna P: Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide. J Allergy Clin Immunol 1996;97: 655-661.
58. Henriksson G, Norlander T, Forsgren J, Stierna P: Effects of topical budesonide treatment on glucocorticoid receptor mRNA downregulation and cytokine patterns in nasal polyps. Am J Rhinol 2001;15: 1-8.
59. Choi BR, Kwon JH, Gong SJ, Kwon MS, Cho JH, Kim JH, Oh S, Roh HJ, Kim DE: Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps. Exp Mol Med 2006;38: 466-473.
60. Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ: Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994;93:33-39.
61. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM: p38 Mitogen-ac-tivated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002;109:649-657.
62. Ismaili N, Garabedian MJ: Modulation of glucocorticoid receptor function via phosphorylation. Ann NY Acad Sci 2004;1024: 86-101.
63. Weigel NL, Moore NL: Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol 2007;21:2311-2319.
64. Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB, Rogatsky I, Logan SK, Garabedian MJ: Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 2008;22: 1754-1766.
65. Tliba O, Cidlowski JA, Amrani Y: CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-α and interferon-γ by a mechanism involving the upregulation of the glucocorticoid receptor β isoform. Mol Pharmacol 2006;69:588-596.
66. Tliba O, Damera G, Banerjee A, Gu S, Baidouri H, Keslacy S, Amrani Y: Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol 2008;38:463-472.
67. Bonville CA, Mehta PA, Krilov LR, Rosenberg HF, Domachowske JB: Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone. Cell Immunol 2001;213: 134-140.
68. Verheggen MM, Adriaansen-Soeting PW, Berrevoets CA, van Hal PT, Brinkmann AO, Hoogsteden HC, Versnel MA: Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD. Mediators Inflamm 1998;7:275-281.
69. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF: Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008;63: 784-790.
70. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR: Anti-inflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 2006;203: 1883-1889.
71. Quante T, Ng YC, Ramsay EE, Henness S, Allen JC, Parmentier J, Ge Q, Ammit AJ: Corticosteroids reduce IL-6 in ASM cells via upregulation of MKP-1. Am J Respir Cell Mol Biol 2008;39:208-217.
72. Pujols L, Mullol J, Benítez P, Torrego A, Xaubet A, de Haro J, Picado C: Expression of the glucocorticoid receptor α and β isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 2003;97: 90-96.
73. Gagliardo R, Chanez P, Vignola AM, Bousquet J, Vachier I, Godard P, Bonsignore G, Demoly P, Mathieu M: Glucocorticoid receptor α and β in glucocorticoid-dependent asthma. Am J Respir Crit Care Med 2000;162: 7-13.
74. Torrego A, Pujols L, Roca-Ferrer J, Mullol J, Xaubet A, Picado C: Glucocorticoid receptor isoforms α and β in in vitro cytokine-induced glucocorticoid insensitivity. Am J Respir Crit Care Med 2004;170:420-425.
75. Li LB, Leung DY, Hall CF, Goleva E: Divergent expression and function of glucocorticoid receptor β in human monocytes and T cells. J Leukoc Biol 2006;79:818-827.
76. Oakley RH, Webster JC, Sar M, Parker CR Cidlowski JA: Expression and subcellular distribution of the β-isoform of the human glucocorticoid receptor. Endocrinology 1997;138: 5028-5038.
77. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH: Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform. J Allergy Clin Immunol 2000;105: 943-950.
78. Hauk PJ, Hamid QA, Chrousos GP, Leung DY: Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000;105: 782-787.
79. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm DJ: Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 1997;186: 1567-1574.
80. Hamid QA, Wenzel SE, Hauk PJ, Tsicopou-los A, Wallaert B, Lafitte JJ, Chrousos GP, Szefler SJ, Leung DY: Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999;159: 1600-1604.
81. Christodoulopoulos P, Leung DY, Elliott MW, Hogg JC, Muro S, Toda M, Laberge S, Hamid QA: Increased number of glucocorticoid receptor-β- expressing cells in the airways in fatal asthma. J Allergy Clin Immunol 2000;106:479-484.
82. Hamilos DL, Leung DY, Muro S, Kahn AM, Hamilos SS, Thawley SE, Hamid QA: GR β expression in nasal polyps inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001;108:59-68.
83. Bergeron C, Fukakusa M, Olivenstein R Lemiere C, Shannon J, Ernst P, Martin JG, Hamid Q: Increased glucocorticoid receptor- β expression, but not decreased histone deacetylase-2, in severe asthma. J Allergy Clin Immunol 2006;117: 703-705.
84. Webster JC, Oakley RH, Jewell CM, Cidlowski JA: Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance. PNAS 2001;98:6865-6870.
85. Fakhri S, Tulic M, Christodoulopoulos P, Fukakusa M, Frenkiel S, Leung DY, Hamid QA: Microbial superantigens induce glucocorticoid receptor β and steroid resistance in a nasal explant model. Laryngoscope 2004;114: 887-892.